Skip to main content

#162014

Melan-In1 cell line

Cat. #162014

Melan-In1 cell line

Cat. #: 162014

Availability: 8-10 weeks

Organism: Mouse

Tissue: Skin

Model: Immortalised non-cancerous cell lines

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Elena Sviderskaya

Institute: St. George's University London

Tool Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Melan-In1 cell line
  • Organism: Mouse
  • Tissue: Skin
  • Morphology: Small, oval-fusiform
  • Model: Immortalised non-cancerous cell lines
  • Description: The melan-ln1, -ln2, ln-3 and ln-4 lines are immortal melanocyte cell lines derived from the skin of neonatal Mlphln/Mlphln null Ink4aArf -/- C57BL6/J mice. The leaden gene product (melanophilin, Mlph) is a Rab27a effector protein involved in melanosome transport and as such, these leaden null melanocytes display perinuclear clustering of pigmented melanosomes. These murine melanocytes are a model of the human disorder Griscelli syndrome in which patients present with hypopigmented skin and hair and immunodeficiencies. These melanocytes are a useful tool for studies of pigmentation genetics and transport of photoprotective eumelanin.
  • Application: Melanocyte cell biology

Applications

  • Application: Melanocyte cell biology

Handling

  • Growth medium: RPMI + FBS (10%) + TPA (200 nM) + cholera toxin (CT) (200 pM)
  • Storage conditions: liquid N2

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.